Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EDIT | AMGN | CELG | GILD | BIIB |
| Company | Editas Medicine | Amgen Inc | Celgene Corp | Gilead Sciences Inc | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 5.70 | 301.75 | 108.01 | 65.43 | 221.52 |
| High | 5.78 | 302.91 | 108.59 | 66.14 | 221.98 |
| Low | 5.60 | 299.48 | 107.27 | 65.16 | 216.08 |
| Last | 5.69 | 299.72 | 108.24 | 65.86 | 217.63 |
| Change | +0.03 | +0.24 | +0.11 | +0.32 | -3.79 |
| % Change | +0.53% | +0.08% | +0.10% | +0.49% | -1.71% |
| Volume | 437,011 | 1,015,063 | 191,230,496 | 1,792,527 | 436,780 |
| 20-Day Average Volume | 1,669,180 | 2,750,467 | 16,188,930 | 7,325,200 | 1,340,797 |
| Previous Close | 5.66 | 299.48 | 108.13 | 65.54 | 221.42 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | No | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.68 | 275.27 | 108.17 | 66.49 | 204.46 |
| 20-Day Raw Stochastic | 35.01% | 63.57% | 63.25% | 29.01% | 84.68% |
| 20-Day Relative Strength | 38.93% | 62.93% | 64.69% | 36.82% | 55.26% |
| Weighted Alpha | -60.15 | +27.97 | +46.30 | -19.39 | -27.91 |
| Today's Opinion | 88% Sell | 40% Buy | 100% Buy | 100% Sell | 56% Sell |
| Previous Opinion | 100% Sell | 24% Buy | 100% Buy | 100% Sell | 56% Sell |
| Last Month's Opinion | 88% Sell | 24% Sell | 100% Buy | 100% Sell | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.44% since 04/30/24 | +9.53% since 04/30/24 | -1.97% since 11/13/19 | +1.08% since 04/30/24 | +1.18% since 04/30/24 |
| Low | 5.21 on 05/01/24 | 273.38 on 05/01/24 | 107.27 on 11/20/19 | 64.33 on 05/03/24 | 213.11 on 05/03/24 |
| High | 5.97 on 05/03/24 | 322.60 on 05/03/24 | 110.53 on 11/14/19 | 66.14 on 05/07/24 | 222.40 on 05/06/24 |
| 1-Month | |||||
| %Chg | -15.15% since 04/05/24 | +11.15% since 04/05/24 | +5.14% since 10/18/19 | -5.28% since 04/05/24 | +6.61% since 04/05/24 |
| Low | 5.11 on 04/25/24 | 260.68 on 04/19/24 | 102.40 on 10/21/19 | 64.33 on 05/03/24 | 189.44 on 04/19/24 |
| High | 7.03 on 04/09/24 | 322.60 on 05/03/24 | 110.70 on 11/13/19 | 69.95 on 04/09/24 | 222.40 on 05/06/24 |
| 3-Month | |||||
| %Chg | -19.81% since 02/07/24 | +1.41% since 02/07/24 | +13.63% since 08/20/19 | -11.44% since 02/07/24 | -9.64% since 02/07/24 |
| Low | 5.11 on 04/25/24 | 260.68 on 04/19/24 | 93.41 on 08/23/19 | 64.33 on 05/03/24 | 189.44 on 04/19/24 |
| High | 11.58 on 02/28/24 | 322.60 on 05/03/24 | 110.70 on 11/13/19 | 76.21 on 03/11/24 | 244.95 on 02/12/24 |
| 6-Month | |||||
| %Chg | -36.36% since 11/07/23 | +10.67% since 11/07/23 | +14.14% since 05/20/19 | -18.24% since 11/07/23 | -11.51% since 11/07/23 |
| Low | 5.11 on 04/25/24 | 260.52 on 11/21/23 | 89.08 on 07/23/19 | 64.33 on 05/03/24 | 189.44 on 04/19/24 |
| High | 11.69 on 12/06/23 | 329.72 on 02/05/24 | 110.70 on 11/13/19 | 87.86 on 01/19/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 465,450 | 160,633,888 | 77,035,920 | 81,602,352 | 32,238,088 |
| Shares Outstanding, K | 82,235 | 536,376 | 711,714 | 1,245,077 | 145,597 |
| Annual Sales | 78,120,000 | 28,190,000,000 | 15,281,000,000 | 27,116,000,000 | 9,835,600,000 |
| Annual Net Income | -153,220,000 | 6,717,000,000 | 4,046,000,000 | 5,665,000,000 | 1,161,100,000 |
| Last Quarter Sales | 60,050,000 | 7,447,000,000 | 4,520,000,000 | 6,686,000,000 | 2,290,500,000 |
| Last Quarter Net Income | -18,870,000 | -113,000,000 | 1,691,000,000 | -4,170,000,000 | 393,400,000 |
| 60-Month Beta | 2.09 | 0.60 | 1.41 | 0.22 | -0.01 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.23 on 02/28/24 | 3.96 on 05/02/24 | 2.99 on 10/31/19 | -1.32 on 04/25/24 | 3.67 on 04/24/24 |
| Latest Earnings Date | 05/08/24 | 05/02/24 | 10/31/19 | 04/25/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.71 | 10.99 | 16.07 | 14.50 |